We saw new cells growing back into these new areas of the lung.
Not exact matches
To read his blog is to watch the growth of a human being: You
see Ev nearly lose his company, bring it back from the dead, strike it big, struggle with the tech support for his
new cell phone, and get married.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for
new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize
cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit
new drug applications for
new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for
new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not
see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
For example, we've
seen new discoveries in health care recently, especially in immuno - oncology therapies, which help the immune systems of cancer patients recognize and destroy cancerous
cells.
New technology building booms and subsequent collapses are, historically normal and common following the introduction of new and transformative technologies, and we have seen them in the US and British automobile industries, the late 20th century communications «tech wreck», the rise and contraction cell phone manufacturers, and the explosion of entry into US telecommunications post «deregulation» in the US, just to cite a f
New technology building booms and subsequent collapses are, historically normal and common following the introduction of
new and transformative technologies, and we have seen them in the US and British automobile industries, the late 20th century communications «tech wreck», the rise and contraction cell phone manufacturers, and the explosion of entry into US telecommunications post «deregulation» in the US, just to cite a f
new and transformative technologies, and we have
seen them in the US and British automobile industries, the late 20th century communications «tech wreck», the rise and contraction
cell phone manufacturers, and the explosion of entry into US telecommunications post «deregulation» in the US, just to cite a few.
Over the last six years the
New York Times regularly ran front - page stories on the latest stem -
cell news, largely to embarrass the Bush administration, and now we rarely
see stem -
cell stories on any page.
One of the consequences of their work is stated in their press release: «With this first synthetic bacterial
cell and the
new tools and technologies we developed to successfully complete this project, we now have the means to dissect the genetic instruction set of a bacterial
cell to
see and understand how it really works.»
Baby Monitors:
See the Risk Wake Up Call:
Cell Phones, Children and Brain Tumors EMF Protection: Renegade Health and Mary Cordaro Nesting: How to Prepare a Health Space for Your Baby The
New Cellphone Study Does Not Include Health Effects on Children
DOWNTOWN BROOKLYN, NY — Peter Liang, the rookie NYPD officer found guilty of manslaughter last month for fatally shooting young, unarmed black man Akai Gurley in a dark East
New York stairwell in 2014, may never
see the inside of a jail
cell.
A longtime Albany reporter was arrested early Wednesday afternoon after he used his
cell phone in the lobby of the
New York State Senate — a move that gave birth to a hashtag movement and
saw Gov. Andrew Cuomo step in to free him.
After exposing supporting
cells —
cells that can create
new cochlear hairs — to a specialized drug mixture, the team
saw significant
new hair
cell growth.
Using the same adaptive optics principles that let astronomers
see distant objects with such instruments as the Keck Telescope, researchers have created a
new device for ophthalmologists to
see the eye's retina at the individual
cell level.
A
new type of human stem
cell, never
seen in nature, should be better at making replacement organs than existing stem
cells
Current treatments are based on the bulk, brute removal of
cells — but miss even a few, and evolution will
see to it that the cancer returns in a
new, often more resistant, form.
TOUGH STUFF A
new wood - compacting process crushes the gaps between
cell walls in natural wood (porous structure
seen in the scanning electron microscopy image, left), making the densified wood (right) as strong as steel.
Stefan W. Hell, Eric Betzig, and William Moerner share the prize for developing
new ways to
see inside a
cell.
In the future the researchers
see using stem
cells taken from patients to grow
new bones.
While previous vectors have only been able to penetrate the cochlea's inner hair
cells, the first Nature Biotechnology study showed that a
new synthetic vector, Anc80, safely transferred genes to the hard - to - reach outer hair
cells when introduced into the cochlea (
see images).
The scientists then tested three
new mTOR inhibitors currently under development (pp242, AZD8055 and INK128) in combination with the chemotherapies AraC, Etoposide and Cisplatin to
see how they affected laboratory lines of leukemia
cells and mouse models of the disease.
With the engineered
cells, researchers can screen
new and existing drugs to
see how they regulate alpha - synuclein level in patients.
They also stopped making
new brain
cells, something that has also been
seen in other animal models of depression.
«But it will be possible to design and develop
new cells to take advantage of what we've
seen.»
In his thirties, he learned about a
new way to stain tissue developed by the Italian Camillo Golgi: a
new silver - based stain that turned some nerve
cells completely black while leaving most others entirely untouched, rendering the delicate branches of the nerve processes clearly visible (as
seen in the image on the left).
It will be relatively easy for the team to monitor the fate of the
new cells because they can be
seen in the eye through a microscope.
Next steps for this research will
see new refinements in the endomicroscope instrument and development of
new tumor
cell stains and probes that light up the tumor
cells to an even greater degree.
Now, with
new kinds of technologies that are coming up,
new types of tissue engineering and, you know, some of the hopes that people have for stem
cells and [the] like, it may be interesting to
see if there are other ways, alternatives to dealing with really badly damaged hearts that would involve growing a
new heart or replacing or repairing the damage d to a badly damaged heart that might make artificial hearts less important in the somewhat more distant future.
Mallat hopes to clarify the role of regulatory T
cells with a
new experiment: injecting the
cells into genetically normal mice with atherosclerosis, to
see whether the
cells can treat the disease.
Some outsiders
see it as an overreaction to the research fiasco, in which the center's Haruko Obokata and colleagues announced what would have been a revolutionary
new way to produce stem
cells.
I think we will also be able to use stem
cells in vitro to screen
new drugs and
see how they are likely to affect the people taking them, making prescriptions safer and more accurate.
Researchers led by Yang Yang, the Carol and Lawrence E. Tannas, Jr., Professor of Engineering at the UCLA Henry Samueli School of Engineering and Applied Science, said the
new cells could serve as a power - generating layer on windows and smartphone displays without compromising users» ability to
see through the surface.
The importance of these neighbour proteins was also
seen in other networks constructed for breast cancer, hepatocellular carcinoma and non-small
cell lung cancer, other «solid» cancers where
new drugs are needed to tackle high mortality rates.
If that fails, Plummer says his lab still may be able to answer the question by looking at the man's T
cells and analyzing whether they have any immunologic memory of having
see the
new virus.
The study can be
seen in
Cell Reports and provides an explanation for why the clinical trials for Alzheimer's disease drugs have failed and gives
new light on the discord between preclinical and clinical findings.
Zon and Kaufman believe that their findings could lead to a
new genetic test for suspicious moles to
see whether the
cells are behaving like neural crest
cells, indicating that the stem -
cell program has been turned on.
Whether stimulating beta
cells to grow will result in therapeutic interventions for diabetes is still to be
seen, but this
new information opens the door to find out, said Sander.
Some basic research findings are being translated into
new treatments, and with the discovery of induced pluripotent stem
cells in 2006, the field has
seen a step - change in biological understanding that will affect the way
new drugs are identified and tested and, potentially, the way
cells can be generated in the lab.
So, the research team put the two together into certain configurations to
see whether the
new caffeine - based gold compounds could selectively stop cancer
cells from growing without hurting other
cells.
So remarked one member of the
New Scientist art department upon
seeing the micrograph of
cell division (far right) that received a special honour at this year's Wellcome Image Awards.
The
new approach builds on information gleaned from developmental studies of embryonic stem
cells (
see story # 16) and one day may be used to create healthy replacements for harmed or diseased tissue.
In the
new study, the researchers cultured mouse skin - cancer colonies on various 2 - D and 3 - D environments of different shapes and patterns to
see if the tumor shape contributes to activation of cancer stem
cells, and to
see where in the tumor the stem
cells appeared.
The size of the brain's ventricles — cerebrospinal fluid - filled spaces deep within the brain — became progressively larger during the course of treatment, and changes were also
seen within the subventricular zone, one of two structures in which
new brain
cells are generated in adults.
It also offers an alternative to the approach used by biologist Craig Venter of building a genome from scratch to impart
new properties to
cells — laborious because even the smallest error kills the
cell (
see «Craig Venter: Why I put my name in synthetic genomes «-RRB-.
A
new method of imaging
cells is allowing scientists to
see tiny structures inside the «control centre» of the
cell for the first time.
Hütter speculates that Brown was helped to a total cure by what is known as the host - versus - graft reaction:
New stem
cells and all their progeny
see the old immune
cells as «other» and kill them off.
NO BARRIER A protein in some
cells that form the blood - brain barrier (light blue, as
seen in this image of a mouse brain capillary) may have a hand in brain aging, a
new study suggests.
The
new methods dramatically improve on the spatial resolution provided by structured illumination microscopy, one of the best imaging methods for
seeing inside living
cells.
Salk scientists and colleagues have proposed
new molecular criteria for judging just how close any line of laboratory - generated stem
cells comes to mimicking embryonic
cells seen in the very earliest stages of human development, known as naïve stem
cells.
As reported in the
new study, the researchers were able to postpone the onset of hearing loss and associated hair
cell degeneration by about a month, providing enough time to inject normal copies of the Clarin - 1 gene into the ear before the onset of hearing loss to
see if the treatment was effective.
Zuo also
saw regeneration of hair
cells from supporting
cells, but most of the
new cells died within 2 weeks.
In a final experiment, the scientists restored Plk4 to
cells lacking both centrioles and p53 to
see if the
cells would make
new centrioles.